2
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Cardiotoxicity
14
Breast Neoplasms
11
Lymphoma, Non-Hodgkin
5
Neoplasms
4
Lymphoma
4
Heart Failure
4
Prostatic Neoplasms
2
Multiple Myeloma
2
Lymphoma, Follicular
2
Lymphoma, B-Cell
2
Leukemia
2
Heart Diseases
2
Cardiovascular Diseases
2
Burkitt Lymphoma
2
Ventricular Dysfunction, Left
1
Ventricular Dysfunction
1
Thoracic Neoplasms
1
Small Cell Lung Carcinoma
1
Radiation Injuries
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Philadelphia Chromosome
1
Peritoneal Neoplasms
1
Obesity
1
Neoplasm, Residual
1
Myeloproliferative Disorders
1
Myelodysplastic Syndromes
1
Metastatic Solid Tumors
1
Metabolic Syndrome
1
Mesothelioma
1
Memory Disorders
1
Interventions
Ibandronic Acid
8
Gemcitabine
8
Doxorubicin
6
Cyclophosphamide
6
Zoledronic Acid
5
Radiation
4
Nivolumab
4
Irinotecan
4
pembrolizumab
3
Vincristine
3
Temozolomide
3
Magnetic Resonance Spectroscopy
3
Ipilimumab
3
Docetaxel
3
Denosumab
3
Cisplatin
3
3-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione
3
regorafenib
2
pegfilgrastim
2
Tranexamic Acid
2
Trabectedin
2
Surveys and Questionnaires
2
Sunitinib
2
Standard of Care
2
Radiotherapy, Intensity-Modulated
2
Radiotherapy
2
Radiosurgery
2
Quality of Life
2
Proton Therapy
2
Observation
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Bone Neoplasms
×
Echocardiography
×
Clear all
NCT04755140
2024-12-16
Endoprosthesis Metal Toxicity Study
Mayo Clinic
Completed
20 enrolled